ABG Sundal Collier acted as sole global coordinator and joint bookrunner in the rights issue of SEK 54 million in Nanologica AB

On 14 March 2024, Nanologica AB (“Nanologica”), the Swedish life science tools company, announced the successful completion of the rights issue of SEK 54 million. The purpose of the rights issue was to finance intensified efforts and investments in the preparative chromatography business area in order to strengthen the company’s competitiveness and take advantage of the favourable market conditions. The proceeds from the rights issue will primarily be used to enable investments in production equipment to optimize production efficiency and production economics, along with investments in sales, marketing, and application support.
ABG Sundal Collier acted as sole global coordinator and joint bookrunner in the transaction and would like to express its gratitude to the Nanologica team for the vote of confidence.